No Data
No Data
Compumedics on Track to Reach Record Revenue in 2024, But Warns of Earnings Miss
Compumedics (ASX:CMP) said it is on track to achieve record revenue for financial year 2024 but likely to miss its profit guidance, according to a Thursday filing with the Australian bourse. The compa
Are Compumedics Limited's (ASX:CMP) Mixed Financials Driving The Negative Sentiment?
Be Wary Of Compumedics (ASX:CMP) And Its Returns On Capital
Compumedics Expects to Hit Record Fiscal H1 Revenue
Compumedics (ASX:CMP) expects fiscal first-half 2024 revenue to rise 35% year over year to a record AU$26.0 million. The medical device company attributed the rise to booking its second magnetoencepha
Compumedics Secures Two Orders for MEG Systems for AU$9.3 Million
Brain research technology company Compumedics (ASX:CMP) received two new orders for its magnetoencephalography system for a combined value of AU$9.3 million. These orders were from the Tsinghua and Ti
US FDA Clears Compumedics' Somfit Device for Marketing in the US; Shares Surge 84%
The US FDA cleared Compumedics' (ASX:CMP) Somfit device to be marketed in the US, the medical laboratory company said Monday. The Somfit device is mainly targeting the home sleep testing market in the
No Data